Found 25 matching trials
Selinexor, Cyclophosphamide and Prednisone in Myeloma PHASE2 The trial is designed as a randomised, controlled, open, parallel group, mu...
Show More Location
Birmingham Heartlands Hospital
Learn More & Join Trial
PERMAD: Personalized Marker-driven Early Switch to Aflibercept in Patients With Metastatic Colorectal Cancer PHASE2 The primary objective of the two phase PERMAD trial is the evaluation of th...
Show More Location
University Medical Center Hamburg-Eppendorf
Learn More & Join Trial
Spatially Fractionated Radiation Therapy for Locally Advanced Cervical Cancer NA This randomized clinical trial will evaluate whether adding spatially fract...
Show More Location
The University of Hong Kong - Shenzhen Hospital,
Learn More & Join Trial
Prophylaxis of Hematologic Complications With Naderin in First-Line Breast Cancer Chemotherapy PHASE2 The goal of this clinical trial is to learn if Naderin works to prevent low...
Show More Location
Multiple Locations
Learn More & Join Trial
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion EARLY_PHASE1 The goal of this study is to determine the response of the study drug lorat...
Show More Location
Children's Hospital Colorado
Learn More & Join Trial
Prophylactic Regimen With Intrathecal Thiotepa in SVZ-positive or Meningeal-risk Glioblastoma PHASE2 The goal of this clinical trial is to test whether adding preventive intrat...
Show More Location
2nd Affiliated Hospital, School of Medicine
Learn More & Join Trial
Anti-EGFR Agents in Patients With Right-sided Advanced Colorectal Cancer With Wild-type RAS and AREG/EREG High Status PHASE4 The aim of this trial is to assess the feasibility of EREG/AREG assessment ...
Show More Location
Multiple Locations
Learn More & Join Trial
Continuation of Cetuximab Beyond First-Line Progression in Metastatic Colorectal Cancer PHASE3 The goal of this Phase 3 clinical trial is to evaluate whether continuing c...
Show More Location
A.O.U. Ospedali Riuniti
Learn More & Join Trial
Study to Improve OS in 18 to 60 Year-old Patients, Comparing Daunorubicin Versus High Dose Idarubicin Induction Regimens, High Dose Versus Intermediate Dose Cytarabine Consolidation Regimens, and Standard Versus MMF Prophylaxis of GvHD in Allografted Patients in First CR PHASE2 This open label, multicenter phase II/III study with multiple randomization...
Show More Location
CH Amiens Hôpital Sud
Learn More & Join Trial
Chemotherapy With Targeted-Immunotherapy for Newly Diagnosed Ph+ ALL NA This is an open-label, prospective clinical cohort study evaluating the eff...
Show More Location
Blood Diseases Hospital
Learn More & Join Trial